Wellness
Microscope Uses Artificial Intelligence to Find Cancer Cells
Artificial intelligence is one of the greatest goals of the 21st century. Major developments in AI do astound, machines learning how to turn words into images and how to beat world class players in Go. A new microscope, developed by researchers from UCLA, uses AI in helping detect and spot blood samples with cancer cells. Faster and more accurate than its contemporary techniques, it can analyze 36 million images every second without damaging the blood samples. The new microscope features something called "photonic time stretch".
Share Your Science: Leveraging Deep Learning for Personalized Drug Treatment Recommendations
David Ledbetter, data scientist at the Children's Hospital Los Angeles, shares how his team is using TITAN X GPUs and deep learning to help provide better recommendations of drug treatments for children in their pediatric intensive care unit. To train their models, 13,000 patient snapshots were created from ten years of electronic health records at the hospital to understand the interactions between a patient's vital state, heart rate, blood pressure and the treatments they were given. By understanding the most important relationships in the data, they are then able to generate the probability of survival predictions for the patients moving forward as well as physiology predictions in order to simulate augmented treatments. David presented his research poster "Dr. Watch more scientists and researchers share how accelerated computing is benefiting their work at http://nvda.ly/X7WpH
Study Identifies Key Factors Associated With Dementia Pathogenesis
Recent research has identified independent predictors of dementia to include age at diagnosis, transient ischemic attack and stroke status, and years of education, with vascular factors playing a greater role in disease pathogenesis than previously thought. The findings were presented at the 2016 annual meeting of the American Academy of Neurology (AAN). In the abstract, the researchers wrote that dementia encompasses a broad set of neurologic diseases, producing progressive declines in memory and/or thinking faculties, sometimes alongside personality and emotional disturbances. "Worldwide, approximately 35.6 million people have dementia, and this number is only expected to grow due to an aging population," they wrote. "Unfortunately, it is exceedingly difficult to predict who will develop dementia, let alone what type. This makes it difficult to mobilize various preventive strategies supported by mounting evidence."
IBM Extends Health Care Bet With Under Armour, Medtronic
IBM announced a deal with sports and fitness retailer Under Armour Inc. to use machine learning technology from Watson and showed off an application for diabetic care developed with the supercomputer's data, highlighting the company's effort to expand Watson's capabilities for the health-care industry. IBM and Under Armour released an updated fitness application for Apple Inc.'s iPhones that uses data powered by Watson, IBM Chief Executive Officer Ginni Rometty said Wednesday in a speech at the International Consumer Electronics Show in Las Vegas. Separately, Medtronic Plc CEO Omar Ishrak joined Rometty on stage to unveil a prototype for a diabetes-management app that tests have shown may be capable of predicting hypoglycemic events as early as three hours in advance. The application still needs to go through regulatory review -- it will roll out this summer, Rometty said. The ability to predict the hypoglycemic events is a "breakthrough," she said.
Artificial intelligence finds cancer cells more efficiently
The "photonic time stretch" was invented by Professor Barham Jalali, who holds a patent for this technology, and its use in microscopes is just one of many possible applications. It works by taking pictures of flowing blood cells using laser bursts in the way that a camera uses a flash. This process happens so quickly โ in nanoseconds, or billionths of a second โ that the images would be too weak to be detected and too fast to be digitised by normal instrumentation. The new microscope overcomes those challenges using specially designed optics that boost the clarity of the images and simultaneously slow them enough to be detected and digitised at a rate of 36 million images per second. It then uses deep learning to distinguish the cancer cells from healthy white blood cells. Deep learning is a form of artificial intelligence that uses complex algorithms to extract meaning from data, with the goal of achieving accurate decision making.
Artificial Intelligence Helps Find Cancer Cells -
A microscope, invented by a professor at the University of California, uses artificial intelligence in order to locate cancer cells more efficiently than ever before. The device uses photonic time stretch and deep learning to analyze 36 million images every second without damaging the blood samples. This new technique for identifying problematic cells is faster and more accurate than standard methods currently in practice. Commonly, doctors will add biochemicals to blood samples in order to check for cells containing cancer. The biochemicals attach what scientists call "biological labels" to damaged cells, which enables instruments to both locate and identify differences.
Can Japan make itself great again by 2050?
The bad news is, Japan is beset by seemingly insoluble problems. The good news is the word "seemingly." No nation whose rise to economic superpowerdom began a bare decade after being bombed to rubble in history's most destructive war will ever find anything truly "insoluble." Give it 34 years, says Clyde Prestowitz. His name rings bells in Japan -- alarm bells mostly, because Prestowitz, an American labor economist who served in the 1980s as economic adviser to the administration of U.S. President Ronald Reagan, earned notoriety here as a prime "Japan basher."
Game over? Computer beats human champ in ancient Chinese game
In a milestone for artificial intelligence, a computer has beaten a human champion at a strategy game that requires "intuition" rather than brute processing power to prevail, its makers said Wednesday. Dubbed AlphaGo, the system honed its own skills through a process of trial and error, playing millions of games against itself until it was battle-ready, and surprised even its creators with its prowess. "AlphaGo won five-nil, and it was stronger than perhaps we were expecting," said Demis Hassabis, the chief executive of Google DeepMind, a British artificial intelligence (AI) company. A computer defeating a professional human player at the 3,000-year-old Chinese board game known as Go, was thought to be about a decade off. The clean-sweep victory over three-time European Go champion Fan Hui "signifies a major step forward in one of the great challenges in the development of artificial intelligence--that of game-playing," the British Go Association said in a statement.
Photonic Time Stretch Microscopy Combined with Artificial Intelligence Spots Cancer Cells in Blood
UCLA researchers have developed a new laser-based technology to rapidly screen blood samples for the presence of cancer cells. The label-free system measures 16 different physical characteristics of each cell and analyzes the data to identify whether the cell is cancerous. Not having to introduce any labeling chemicals and being gentle on the cells, the technique leaves the cells alive and available for further inspection using other means. It relies on a photonic time stretch microscope and a computer that runs deep learning artificial intelligence algorithms. The microscope can take millions of images per second thanks to unusual optics that produce high quality shots even at this speed.
Will mobile health apps make GPs redundant?
You have a fever, can't eat and you're barely strong enough to get out of bed. So you phone your GP surgery for an appointment, only to be told that the first one is two weeks away. A mobile app, Your.MD, is promising something radically different. Billed as a personal health assistant, it uses artificial intelligence (AI) to mimic, as far as possible, your consultation with a GP. If you tell Your.MD your symptoms, it will tell you what it thinks your problem might be.